Biogen (BIIB) Total Debt (2009 - 2026)
Biogen (BIIB) reported Total Debt of $7.29 billion for Q3 2026, up 16.0% from $6.29 billion a year earlier and unchanged from the prior quarter.
Analysis
Biogen (BIIB) Total Debt (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen posted Total Debt of $6.29 billion, down 0.1% from FY2024.
- Total Debt has a five-year compound annual growth rate of -3.3% (FY2020 to FY2025).
- By year, Total Debt came in at $6.3 billion in FY2024 (-9.3%), $6.94 billion in FY2023 (+10.5%), $6.28 billion in FY2022 (-24.1%) and $8.27 billion in FY2021 (+11.4%).
- The Q3 2026 figure ranks as the highest quarterly Total Debt since Q1 2025.
- Year over year, Total Debt gained in three of the last eight quarters, with an average decline of 0.3%.
- The high point for year-over-year Total Debt in five years was Q1 2025 (growth of 18.5%); the low point was Q1 2023 (a decline of 24.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $7.29 billion (Q2 2026), $6.29 billion (Q1 2026) and $6.29 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 49.50 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 80.90 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 53.78 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -6.68 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 54.01 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 26.23 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 62.67 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 7.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.29 Bn |
| Jun 30, 2026 | 7.29 Bn |
| Mar 31, 2026 | 6.29 Bn |
| Dec 31, 2025 | 6.29 Bn |
| Sep 30, 2025 | 6.29 Bn |
| Jun 30, 2025 | 6.28 Bn |
| Mar 31, 2025 | 8.05 Bn |
| Dec 31, 2024 | 6.30 Bn |
| Sep 30, 2024 | 8.04 Bn |
| Jun 30, 2024 | 6.29 Bn |
| Mar 31, 2024 | 6.79 Bn |
| Dec 31, 2023 | 6.94 Bn |
| Sep 30, 2023 | 6.79 Bn |
| Jun 30, 2023 | 6.28 Bn |
| Mar 31, 2023 | 6.28 Bn |
| Dec 31, 2022 | 6.28 Bn |
| Sep 30, 2022 | 6.28 Bn |
| Jun 30, 2022 | 8.28 Bn |
| Mar 31, 2022 | 8.27 Bn |
| Dec 31, 2021 | 8.27 Bn |
API Access
Biogen Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=BIIB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();